By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751



Company News
Approving Sarepta (SRPT)'s DMD Drug Could Force FDA To Get Creative 5/26/2016 7:44:39 AM
Sarepta (SRPT) Rockets After the FDA Delays Ruling on DMD Drug 5/25/2016 5:52:53 AM
Sarepta (SRPT) Who? This DMD Drugmaker Might be a Better Buy for Investors 5/20/2016 6:40:26 AM
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/11/2016 11:10:15 AM
Betting Intensifies Over Sarepta (SRPT)’s DMD Drug 5/6/2016 7:39:20 AM
Sarepta (SRPT) Announces First Quarter 2016 Financial Results And Recent Corporate Developments 5/5/2016 10:49:03 AM
Why Sarepta (SRPT) Didn't Start a Big DMD Trial Quicker 5/3/2016 11:39:46 AM
As Sarepta (SRPT) And Valeant (VRX) Exit Hearings, Biotech Steps Into M&A 5/3/2016 7:26:27 AM
Rounding Up the Experts’ Thoughts on What's Next for Sarepta (SRPT)'s DMD Drug 4/27/2016 6:51:32 AM
FDA Panel’s 7-6 Vote Against Sarepta (SRPT)’s DMD Drug Underlines Battle Between Science and Patient Advocates 4/26/2016 6:20:20 AM